Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Radiology

Can a Fibroadenoma Biopsy Be Accurate If the Lump Remains?

At a Glance

Yes. A benign core needle biopsy can be accurate even when you still feel the breast lump because the procedure usually removes only small tissue samples, not the fibroadenoma. Imaging and tissue results should agree; growth or new changes need medical review.

It is usually expected to still feel the lump after a benign breast biopsy. A core needle biopsy is designed to take small samples of tissue for testing, not to remove the entire mass [1]. Because the fibroadenoma is left in place, you will likely still be able to feel it after the procedure. Additionally, the breast may feel temporarily different due to post-biopsy bruising, swelling, or a small collection of blood (hematoma)—this is common and does not mean the biopsy missed the lesion.

Understanding Radiology-Pathology Concordance

The accuracy of your biopsy relies heavily on radiology-pathology concordance and whether the sample collected was adequate [2]. Concordance means that the pathologist’s findings under the microscope (a benign fibroadenoma) match how the lump felt to your doctor and how it looked on your ultrasound or mammogram [3].

If the mass looked like a typical fibroadenoma on imaging, the sample was adequate, and the biopsy confirmed a fibroadenoma, your team will consider the results concordant [4]. While no test is an absolute guarantee, a concordant benign biopsy makes cancer highly unlikely. In these cases, your doctor will likely recommend a personalized schedule for active surveillance or routine age-appropriate screening, depending on your age, the lump’s size, and your preferences [5].

When to Consider Repeat Biopsy or Surgery

While feeling the original lump is expected, there are specific situations where your care team might recommend further evaluation, a repeat biopsy, or surgical removal:

  • Discordant results or inadequate sampling: If the lump looked highly suspicious on imaging but the biopsy came back as a benign fibroadenoma, the results are considered “discordant” [2]. Your doctor will investigate further to ensure the needle adequately sampled the concerning area [6].
  • Indeterminate findings (Fibroepithelial Lesions): Sometimes a core biopsy cannot easily distinguish between a fibroadenoma and a phyllodes tumor—an uncommon type of tumor that can be benign, borderline, or malignant [7]. If your pathology report says “fibroepithelial lesion” or “cannot exclude phyllodes,” your doctor may recommend excision to be certain.
  • Persistent or rapid growth: Fibroadenomas can sometimes grow slowly, but rapid or substantial enlargement requires reassessment to rule out other conditions like a phyllodes tumor [7].
  • New or concerning changes: While it is very rare for cancer to develop within a fibroadenoma, any new or worsening breast changes should be evaluated [8][9]. Contact your doctor if you notice rapid enlargement, skin dimpling or thickening, nipple retraction, unusual bloody discharge, or a new underarm lump. (Note: Mild pain or tenderness is commonly benign and can be related to the biopsy itself or hormonal changes).

Understanding Surgical Excision

If there is uncertainty about the diagnosis, if the lump is growing, or if it causes you significant physical discomfort or anxiety, you and your doctor might discuss surgical excision [1][3]. Excision involves removing the entire mass. This is one option, not an automatic requirement, and the decision should weigh the benefits of removal against the risks of surgery, such as scarring or changes in breast contour.

(Safety Note: If you recently had a biopsy, contact your care team immediately if you experience signs of infection or complications, such as worsening redness, warmth, fever, heavy uncontrolled bleeding, or rapidly increasing swelling.)

Common questions in this guide

Why can I still feel the lump after a benign fibroadenoma biopsy?
A core needle biopsy removes small tissue samples for testing; it usually does not remove the fibroadenoma itself. The lump may therefore remain palpable, and bruising, swelling, or a small collection of blood can temporarily change how the breast feels.
How do doctors know whether a benign fibroadenoma biopsy is reliable?
They compare what the tissue looked like under a microscope with the lump’s examination and its ultrasound or mammogram appearance, and they check that enough tissue was sampled. When these findings agree, called radiology-pathology concordance, a benign biopsy makes cancer highly unlikely, although no test is an absolute guarantee.
When should a benign fibroadenoma biopsy be checked again?
Further evaluation may be needed if the imaging looked suspicious, the sample was inadequate, or the report says “fibroepithelial lesion” or “cannot exclude phyllodes tumor.” Rapid growth or new changes such as skin dimpling, nipple retraction, bloody discharge, or a new underarm lump also warrant prompt medical review.
Does a lump that stays after biopsy mean the biopsy missed cancer?
Not necessarily; a core biopsy is meant to sample the lump, while the original mass usually remains. If the imaging, examination, and tissue result do not match, or if the lump grows quickly, your clinician may recommend another biopsy or removal.
Can a benign fibroadenoma be surgically removed?
Yes, removal may be discussed if the diagnosis is uncertain, the lump is growing, or it causes significant discomfort or anxiety. Excision removes the entire mass, but the decision should balance possible benefits with risks such as scarring or changes in breast contour.
What symptoms after a breast biopsy need immediate medical attention?
Contact your care team immediately for worsening redness or warmth, fever, heavy uncontrolled bleeding, or rapidly increasing swelling. Mild tenderness can occur after a biopsy or with hormonal changes, but new or worsening breast changes should still be assessed.

Get notified when new evidence is published on breast fibroadenoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    Triple-negative Breast Cancer Arising in a Fibroadenoma in BRCA 1 Mutated Patient.

    Brunetti N, Valente I, Pitto F, Calabrese M

    Journal of medical ultrasound 2023; (31(1)):63-65 doi:10.4103/jmu.jmu_83_21.

    PMID: 37180614
  2. 2

    Reducing False Negatives in Biopsy of Suspicious MRI Findings.

    Wang LC, Rao S, Schacht D, Bhole S

    Journal of breast imaging 2023; (5(5)):597-610 doi:10.1093/jbi/wbad024.

    PMID: 38416912
  3. 3

    Evaluating imaging-pathology concordance and discordance after ultrasound-guided breast biopsy.

    Park VY, Kim EK, Moon HJ, et al.

    Ultrasonography (Seoul, Korea) 2018; (37(2)):107-120 doi:10.14366/usg.17049.

    PMID: 29169231
  4. 4

    Demystifying Breast Disease Markers.

    Wells VA, Medeiros I, Shevtsov A, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2023; (43(10)):e220151 doi:10.1148/rg.220151.

    PMID: 37676826
  5. 5

    Management of intraductal papilloma without atypia of the breast diagnosed on core biopsy: Size and sampling matter.

    Symbol B, Ricci A

    The breast journal 2018; (24(5)):738-742 doi:10.1111/tbj.13052.

    PMID: 29687535
  6. 6

    Discrepancies between radiological and histological findings in preoperative core needle (CNB) and vacuum-assisted (VAB) breast biopsies.

    Jörg I, Wieler J, Elfgen C, et al.

    Journal of cancer research and clinical oncology 2021; (147(3)):749-754 doi:10.1007/s00432-020-03481-7.

    PMID: 33284380
  7. 7

    Imaging and Management of Fibroepithelial Lesions of the Breast: Radiologic-Pathologic Correlation.

    Zhang M, Arjmandi FK, Porembka JH, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2023; (43(11)):e230051 doi:10.1148/rg.230051.

    PMID: 37856317
  8. 8

    An Uncommon Pairing of common Tumors: Case Report of Ductal Carcinoma in situ Within Fibroadenoma.

    Marumoto A, Steinemann S, Furumoto N, Woodruff S

    Hawai'i journal of medicine & public health : a journal of Asia Pacific Medicine & Public Health 2019; (78(2)):39-43.

    PMID: 30766763
  9. 9

    A case of fibroadenoma with lobular carcinoma in situ and microinvasion in a young woman.

    Wang M, Leong MY, Tan QT

    Journal of surgical case reports 2022; (2022(12)):rjac602 doi:10.1093/jscr/rjac602.

    PMID: 36601097

This page is for informational purposes only and does not constitute medical advice. Your radiologist, pathologist, or breast specialist can determine whether your biopsy and imaging are concordant and what follow-up you need.